Moçambique. Manual de biossegurança e bioprotecção do instituto nacional de saúde / Biosafety and bioprotection manual of the national institute of health

Ao efectuarmos a revisão deste manual pretendemos apresentar uma nova dinâmica sobre os principais conceitos relativos a Biossegurança e Bioprotecção, suas interfaces essenciais e permitir que esses conhecimentos teóricos se desdobrem em acções práticas no dia-a-dia dos funcionários e colaboradores do e no INS, das re presentações locais, bem como da Rede de Laboratórios de Saúde Pública Humana do Sistema Nacional de Saúde (SNS). Nesta 2ª edição do manual iremos aprimorar os conceitos sobre Biossegurança, Bioprotecção, Biorisco e outros perigos que podem ocorrer em laboratórios, avaliação de riscos, níveis de biossegurança laboratorial, medidas de protecção individual e colectivas classifica das em barreiras primárias e secundárias, de controlo administrativos e de engenharia, adopção de boas práticas microbiológicas e de pro cedimentos (BPMP), medidas de precaução aceites universalmente e promoção da cultura do comportamento organizacional, iniciativas que induzam a manipulação segura de agentes e doenças emergentes e re-emergentes de carácter epidémico, endémico ou pandémico rumo a manutenção da segurança global em saúde…

Manual de biossegurança e bioprotecção 2ª edição, 2022 / Biosafety and bioprotection 2nd edition, 2022

A Biossegurança e Bioprotecção em Laboratórios de Saúde Pública, Laboratórios de Análises Clínicas e instituções de pesquisa em saúde são áreas do conhecimento relativamente novas, reguladas em vários países por um conjunto de leis, normas, directrizes e procedimentos específicos. Actualmente, a Biossegurança e a Bioprotecção são vistas como disciplinas científicas que requerem um domínio de conhecimentos, habilidades e atitudes (CHA) multi-disciplinares. A aplicação dos princípios de Biossegurança e Bioprotecção é essencial para conter, prevenir, reduzir e eliminar os riscos de exposição por agentes microbiológicos, químicos, físicos, ergonómicos, acidentais e entre outros perigos que podem ou poderiam causar doenças de âmbito ocupacional. A Biossegurança e a Bioprotecção são também importantes para prevenir a exposição a riscos aos familiares de profissionais de saúde, utentes dos serviços de saúde, e para garantir a protecção do meio ambiente e da vida selvagem

High level of HIV false positives using EIA-based algorithm in survey: Importance of confirmatory testing.

The Mozambique Indicators of Immunization, Malaria and HIV/AIDS (IMASIDA) survey was conducted in 2015 and used a two Enzyme Immunoassay (EIA) (Vironostika HIV-1/2 and Murex HIV-1/2) based algorithm to determine the HIV status of the consented participants. The Mozambique Ministry of Health, with support from the US Centers for Disease Control and Prevention (US CDC), added Bio-Rad Geenius™ HIV-1/2 Supplemental Assay to the IMASIDA HIV testing algorithm to confirm all specimens that were found to be reactive on one or both EIAs. In total 11690 specimens were collected to estimate the proportion of HIV positive samples. Results indicate that the proportion of HIV positive samples based on the concordant positive results of two EIA assays was 21.5% (2518/11690). The addition of the Geenius assay to the IMASIDA HIV testing algorithm demonstrated that 792 (31.5%) of 2518 specimens were false-positive and reduced the proportion of HIV positive samples to 14.7% (1722/11690), demonstrating the importance of including a highly specific HIV test to confirm HIV diagnosis. HIV surveys exclusively based on EIA testing algorithm may result in misleading high prevalence results. Our results demonstrate that more specific confirmatory testing should be added to the EIA-based algorithms to ensure accurate HIV diagnosis and correct HIV prevalence estimate in cross-sectional surveys.

High Burden of HIV Infection and Risk Behaviors Among Female Sex Workers in Three Main Urban Areas of Mozambique.

This is the first integrated biological and behavioral survey among female sex workers (FSW) in Mozambique. Using respondent-driven sampling, 400, 411 and 429 FSW were enrolled respectively in Maputo, Beira and Nampula in 2011-2012. Estimates were produced using RDSAT 7.1. HIV prevalence was 31.2, 23.6, and 17.8 % in each location respectively. Among HIV-positive FSW, 48.1, 79.8 and 89.6 % in each city, were unaware of their serostatus. Condom use at last sex with a client was 85.8, 73.4 and 62.8 % among FSW, respectively. HIV was associated with current age, age of first sex for money, low educational level, and having had a genital ulcer in the last 6 months. Results suggest the urgent need to increase behavioral and structural interventions in this key population.

Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.

BACKGROUND: Screening for human T-lymphotropic virus-1/2 (HTLV-1/2) infection is not performed in blood banks in Mozambique. The aim was to determine the prevalence of HTLV-1/2 among blood donors of the Maputo Central Hospital Blood Bank and measure the coinfection rate of HTLV-1/2 with human immunodeficiency virus (HIV), hepatitis B virus (HBV), and syphilis. STUDY DESIGN AND METHODS: A total of 2019 consecutive blood donors were screened for HTLV-1/2 antibodies, HIV-1/2 antibodies, hepatitis B surface antigen (HBsAg), and rapid plasma reagin (RPR) for syphilis. Specimens reactive on a first HTLV-1/2 enzyme immunoassay (EIA) were retested using a second EIA. Specimens that were dually reactive on both EIAs were further tested using Western blot (WB) and real-time polymerase chain reaction (PCR). RESULTS: All 18 dually reactive specimens (0.89%; 95% confidence interval, 0.48%-1.30%) were positive for the presence of HTLV-1 by WB and real-time PCR. HTLV-2 was not detected. The prevalences of anti-HIV, HBsAg, and reactivity in the RPR test were 5.72, 6.01, and 0.98 percent, respectively. There was no significant association between HTLV-1 infection and demographic variables (age and sex) or serologic markers (HIV, HBsAg, and RPR). For the 17 HTLV-1-positive donors for whom serologic data for HIV, HBsAg, and syphilis RPR were available, 2 showed coinfection with HIV and 1 with HBV. CONCLUSION: Compared to other infectious agents, HTLV-1 is present at relatively low levels among blood donors in Mozambique. Cost and logistics will present as major challenges for introducing HTLV-1/2 screening in blood banks. In blood banks in Southern Africa where EIA testing is possible, a sequential algorithm of two EIAs may be a cost-efficient option for HTLV-1/2 screening.